Eversept Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $41.5M | Buy |
|
|||||
|
2025
Q2 | $26.6M | Buy |
|
|||||
|
2025
Q1 | $18.6M | Buy |
|
|||||
|
2024
Q4 | $15M | Buy |
|
|||||
|
2024
Q3 | $15.7M | Buy |
|
|||||
|
2024
Q2 | $7.38M | Buy |
|
|||||
|
2024
Q1 | $2.49M | Buy |
|
|||||
|
2023
Q4 | $2.99M | Sell |
|
|||||
|
2023
Q3 | $6.8M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $9.81M | Buy |
|
|||||
|
2022
Q2 | $5.16M | Buy |
|
|||||
|
2022
Q1 | $2.88M | Sell |
|
|||||
|
2021
Q4 | $3.85M | Buy |
|
|||||
|
2021
Q3 | $2.63M | Buy |
|